Orally active tolciclate .[.(and tolnaftate).].

Abstract

It has been found that fungal diseases can be effectively treated systemically by oral administration of tolciclate .[.or tolnaftate.].. The .[.drugs.]. .Iadd.drug .Iaddend.will generally be administered in divided daily doses in the form of tablets, capsules, syrups or suspensions.

What we claim and desire to protect by Letters Patent is: 
     
       1. A process of suppressing fungal disease which comprises orally administering to a person infected therewith a therapeutically effective amount for antifungal purposes of .[.an antifungal agent selected from the group consisting of.]. tolciclate .[.and tolnaftate.].. 
     
     
       2. The process of claim 1 where the .[.antifungal agent.]. .Iadd.tolciclate .Iaddend.is administered in the form of a tablet. 
     
     
       3. The process of claim 1 where the .[.antifungal agent.]. .Iadd.tolciclate .Iaddend.is administered in the form of a capsule. 
     
     
       4. The process of claim 1 wherein the .[.antifungal agent.]. .Iadd.tolciclate .Iaddend.is administered in the form of a liquid suspension. 
     
     
       5. The process of claim 1 wherein the .[.antifungal agent.]. .Iadd.tolciclate .Iaddend.is administered in divided daily doses. .[.6. the process of claim 1 where the antifungal agent is tolciclate..]. .[.7. The process of claim 1 where the antifungal agent is tolnaftate..].